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Brain endothelial cells form a paracellular and trans-
cellular barrier to many blood-borne solutes via tight
junctions (TJs) and scarce endocytotic vesicles. The
blood-brain barrier (BBB) plays a pivotal role in the
healthy and diseased CNS. BBB damage after
ischemic stroke contributes to increased mortality,
yet the contributions of paracellular and transcellular
mechanisms to this process in vivo are unknown. We
have created a transgenic mouse strain whose endo-
thelial TJs are labeled with eGFP and have imaged
dynamic TJ changes and fluorescent tracer leakage
across the BBB in vivo, using two-photon micro-
scopy in the t-MCAO stroke model. Although barrier
function is impaired as early as 6 hr after stroke, TJs
display profound structural defects only after 2 days.
Conversely, the number of endothelial caveolae and
transcytosis rate increase as early as 6 hr after
stroke. Therefore, stepwise impairment of transcellu-
lar followed by paracellular barrier mechanisms
accounts for the BBB deficits in stroke.
INTRODUCTION
Stroke is a complex and devastating neurological condition that
is the fourth-leading cause of death and the primary reason for
disability in the U.S. (Go et al., 2013). Although several processes
that cause ischemic damage to neurons, glia, and brain micro-
vessels during ischemic stroke have been described, the
response of the neurovascular unit (NVU) to this disease is poorly
understood (del Zoppo, 2010; Arai et al., 2011). In particular, the
precise cell biological mechanisms that impair blood-brain bar-rier (BBB) integrity in vivo after stroke are unknown. Endothelial
cells (ECs) that survive in the perinfarct region, but do not main-
tain BBB properties, facilitate damage to the adjacent paren-
chyma and exacerbate the clinical prognosis. Thus, it is crucial
to understand how ECs respond in vivo to ischemic injury in
order to develop therapies that may halt disease progression
(Gursoy-Ozdemir et al., 2012).
ECs are crucial components of the ischemic response
because they normally create a barrier that limits diffusion of
blood-borne solutes. There are three critical characteristics of
brain endothelium that establish this barrier: (1) tight junctions
(TJs) that restrict diffusion of molecules; (2) a small number of
endocytotic vesicles and lowered rates of transcytosis relative
to peripheral vasculature; and (3) active transport of molecules
between blood and brain (Abbott et al., 2010). TJs restrict para-
cellular diffusion of ions between ECs, leading to the high trans-
endothelial electrical resistance (TEER) of the BBB (Brightman
and Reese, 1969; Butt et al., 1990). Claudin5 and Claudin12,
the major functional constituents of endothelial TJs, create
size- and charge-selective hydrophilic paracellular pores (Morita
et al., 1999; Anderson and Van Itallie, 2009), and Claudin5 plays
an essential role in paracellular permeability to small molecules
(<800 Da) at the BBB (Nitta et al., 2003). During reperfusion after
ischemic stroke, there is a biphasic increase in BBB permeability
that contributes directly to cerebral vasogenic edema, hemor-
rhage, and increased mortality.
The prevailing model suggests that active disassembly and
reassembly of TJ protein complexes in CNS ECs accounts for
both phases of BBB breakdown during reperfusion (Sandoval
and Witt, 2008; Luissint et al., 2012). Hypoxic conditions
alter both expression levels and localization of Claudin5 and
reduce TEER in brain EC lines or isolated microvessels in vitro.
Enzymatic degradation of the extracellular matrix by leukocyte-
derived matrix metalloproteinases (MMPs), release of inflamma-
tory cytokines within the ischemic core or peri-infarct area, and
secretion of vascular endothelial growth factor (VEGF) have allNeuron 82, 603–617, May 7, 2014 ª2014 Elsevier Inc. 603
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(Rosenberg and Yang, 2007; Arai et al., 2011; Lakhan et al.,
2013). Although defective TJ morphology has been reported as
early as 3 hr after ischemia in rodents in conjunction with
reduced levels of Claudin5, Occludin, and Zona Occludens-1
(ZO-1), ultrastructural analysis of TJs during disease progression
has produced no convincing evidence that TJ disruption is
responsible for the early phase of BBB breakdown (Lossinsky
and Shivers, 2004; Jiao et al., 2011; Krueger et al., 2013). On
the contrary, TJ morphology remains normal even after 25 hr
of cerebral ischemia after embolic middle cerebral artery occlu-
sion (MCAO), despite profuse extravasation of tracers from
blood vessels (Krueger et al., 2013). These findings suggest
that active remodeling of TJ complexes may occur in the late
phase of reperfusion, when angiogenesis of CNS vessels begins
(Arai et al., 2009).
In addition to the paracellular barrier, CNS blood vessels also
provide a transcellular barrier by virtue of their small number of
endocytotic caveolae having a low rate of transcytosis (Nag,
2003). Ultrastructural analysis suggests that enhanced transcel-
lular transport may be the initial response of the CNS endothe-
lium in stroke. This alternative mechanism for BBB opening
involves upregulation in the number of endocytotic vesicles,
which have been visualized by transmission electronmicroscopy
(TEM) in conjunction with increased uptake of tracers by ECs in
several stroke models (Ito et al., 1980; Dietrich et al., 1987;
Cipolla et al., 2004; Lossinsky and Shivers, 2004). This mecha-
nism of barrier disruption has to date been largely overlooked.
Caveolae are intermediaries in the endocytotic pathway and
contain receptors for proteins that must cross the BBB (Simio-
nescu et al., 2009). Both expression of Caveolin1 (Cav1) and
its phosphorylation state are increased as early as 2 hr after
CNS injury, prior to disassembly of TJ complexes and BBB
breakdown (Nag et al., 2007). Cav1 interacts with Claudins and
Occludin (Itallie and Anderson, 2012) and can influence their
intracellular trafficking in response to inflammation (Stamatovic
et al., 2009; Marchiando et al., 2010; Liu et al., 2012a). Despite
the paramount role that BBB impairment plays in stroke, it is
unclear whether increased endothelial caveolae at early phases
of reperfusion precedes TJ remodeling in vivo, and whether
these two cell biological mechanisms regulating transcellular
and paracellular barrier properties are connected.
To address these issues, we have created a transgenic mouse
strain, Tg eGFP-Claudin5, expressing a fusion of eGFP with
Claudin5 in all CNS ECs. We have measured changes in struc-
tural TJ protein localization and BBB permeability in the transient
MCAO (t-MCAO) model for stroke by performing two-photon,
time-lapse microscopy (Nimmerjahn et al., 2005; Nimmerjahn,
2012c) in the cortex of anesthetized Tg eGFP-Claudin5 mice,
together with intravenous injection of fluorescent tracers. We
find that TJs are stable during early phases of reperfusion, up
to 24 hr after t-MCAO, but undergo significant remodeling and
localization changes starting at 48–58 hr after t-MCAO, a rela-
tively late time point after BBB breakdown. We corroborate
these findings by immunofluorescence and TEM, which reveal
decreased expression levels of Occludin and ZO-1 as well as
ultrastructural changes in endothelial TJs at late stages of reper-
fusion. In contrast, the number of endothelial caveolae and rates604 Neuron 82, 603–617, May 7, 2014 ª2014 Elsevier Inc.of endocytosis and transcytosis are found to increase as early as
6 hr after t-MCAO and to precede both disruption of TJ
morphology and enhanced paracellular BBBpermeability. More-
over, in Cav1-deficient mice, we find that transcellular but not
paracellular permeability of cortical blood vessels is reduced
after t-MCAO, suggesting that Cav1 regulates changes in trans-
cellular but not paracellular endothelial barrier properties in
response to stroke.
RESULTS
Transgenic BBB Reporter Mice and Live Imaging of
Normal Barrier
To correlate structural alterations in TJs at the barrier with func-
tional changes in vessel permeability, we created a transgenic
mouse strain expressing a fusion of eGFP with Claudin5 protein
in all ECs, under control of the endothelial Tie-2/Tek-1 promoter/
enhancer (Evans et al., 2000) (Figure 1A). We examined the
expression and distribution of eGFP-Claudin5 protein in brain,
retina, liver, and muscle of this strain. The fusion protein local-
izes to cell junctions of brain and retinal blood vessels by
confocal and in vivo two-photon microscopy (Figures 1B–1F)
and colocalizes with the barrier-specific, TJ-associated proteins
Occludin and ZO-1 (Figures 1J–1M). However, eGFP-Claudin5
is retained predominantly in the secretory pathway of liver and
muscle endothelial capillaries, but not larger caliber vessels
(Figures S1A–S1B0 available online), suggesting that CNS
ECs regulate proper localization of the fusion protein to cell
junctions.
We compared eGFP-Claudin5 protein levels to endogenous
Claudin5 in brain and liver blood vessels, using quantitative
infrared western blotting. The Tg eGFP-Claudin5 mice have a
2-fold increase in total Claudin5 levels as compared to wild-
type mice, with equal amounts of the endogenous and fusion
proteins (Figures 1G–1I), yet have similar levels of Occludin,
Cav1, and the BBB transporter Slc2a1 (Glut-1) proteins with
wild-type littermates (Figures S1D–S1F; data not shown). A
small fraction (4.7%) of myeloid and lymphoid lineage cells
in Tg eGFP-Claudin5 mice are also eGFP positive (Figure S1C;
Table S1). Since Claudin5 regulates BBB paracellular perme-
ability (Nitta et al., 2003), we determined whether expression
of the fusion protein in ECs impairs vascular permeability to
small molecules in the CNS or other organs. We examined the
biodistribution of a small molecular weight (MW) fluorescent
tracer, 5-(and-6-) tetramethylrhodamine biocytin (biocytin-
TMR, MW = 869 Da) after tail vein injection into healthy Tg
eGFP-Claudin5 or wild-type animals. Biocytin-TMR ordinarily
crosses the BBB only when paracellular permeability is
enhanced (Baur and Baumgartner, 2000) since the Na+-depen-
dent multivitamin transporter Slc5a6, responsible for biotin
transport, is not expressed by CNS ECs (Daneman et al.,
2010a; Ohkura et al., 2010). We found that biocytin-TMR is
absent from brains of transgenic mice but distributed at levels
similar to those of wild-type littermates in liver, muscle, and
other organs (Figures S1G–S1I; data not shown). Therefore,
overexpression of eGFP-Claudin5 protein in blood vessels
does not decrease the paracellular permeability of non-CNS
vasculature.
Figure 1. Genetic Labeling of Endothelial Tight Junctions with eGFP
(A) Diagram of eGFP-Claudin5 fusion protein localization within endothelial cells (ECs) in transgenic mice.
(B–D) Maximum intensity projection images showing 120-mm-thick cortical volumes recorded with two-photonmicroscopy in an anesthetized Tg eGFP-Claudin5
transgenic mouse. eGFP labels TJs between ECs in venules (B, small yellow rectangle; C, yellow arrows) and capillaries (B, large yellow rectangle; D; yellow
arrows).
(E and F) Visualization of TJs in retinal blood vessels with eGFP. Griffonia (Bandeiraea) simplicifolia Lectin I (BSL) labels blood vessels (F).
(G andH)Western blots with brain and liver lysates from Tg eGFP-Claudin5 andwild-typemice for Claudin5 (G) and b-actin (H; 42 kDa). The eGFP-Claudin5 fusion
is approximately 56 kDa and wild-type Claudin5 is 24 kDa.
(I) Quantitation of relative amounts of Claudin5 protein in transgenic and wild-type mice. Levels of Claudin5 protein in wild-type mice were used as a standard
(100%, dotted line, blue bars). Levels of Claudin5 protein in transgenic mice are presented as a percentage of protein levels in wild-type mice, each being
normalized to its respective b-actin control. Transgenic animals have almost twice the amount of Claudin5 protein, from both the endogenous locus (blue bars)
and the transgene (green bars).
(J–M) The fusion protein is localized to TJs in brain ECs (J), together with Occludin (K) and ZO-1 (L) in the merged panel (M). See Figure S1 for expression of the
fusion protein in other organs. Scale bars, 50 mm.
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Tg eGFP-Claudin5 Cortical Endothelium after Stroke
Using in vivo two-photon microscopy, we imaged TJs in parietal
cortex blood vessels from anesthetized Tg eGFP-Claudin5
transgenic mice prepared with either a cranial window and intact
dura mater or a polished and reinforced thinned skull window
(diameter 1.5–2.0 mm) (Nimmerjahn, 2012c; Drew et al., 2010).
We combined TJ imaging in CNS capillaries with injection of
two tracers, biocytin-TMR (870 Da) or dextran-TMR (3 kDa),
to correlate structural changes in TJ protein localization with
functional integrity of the BBB as measured by tracer diffusion
into the CNS parenchyma. In healthy animals with a cranial win-dow, we found that TJs are stable, and both tracers remained
confined within the vessel lumen (Figure 2C; Movie S1; data
not shown). However, a small fraction (4.5%) of eGFP+ TJ
strands (see definition in Experimental Procedures section) con-
tained small gaps (TJ strand discontinuities of at least0.4 mm in
length) or protrusions (bulbous extensions from an otherwise
linear TJ strand within the endothelial cell; Figures 2K–2O), two
structural features that are found during TJ remodeling (Shen
et al., 2008).
We next examined changes in TJ localization and BBB func-
tional impairment during stroke progression in vivo with two-
photon microscopy, using the t-MCAO model. Previous studiesNeuron 82, 603–617, May 7, 2014 ª2014 Elsevier Inc. 605
Figure 2. Integrity of Cortical Blood Vessel
TJs Is Impaired at Late but Not Early
Time Points after Stroke in Live Tg eGFP-
Claudin5 Mice
(A and B) Diagram of the experimental procedure
(A) and cortical region where in vivo two-photon
imaging was performed in Tg eGFP-Claudin5
mice (B).
(C–F) Maximum intensity projections of 120-mm-
thick cortical volumes from healthy mouse brain
(C) and 12–14 hr (D), 24–30 hr (E), and 48–58 hr (F)
after t-MCAO obtained with two-photon imaging
through a cranial window. The imaging areas were
located within the stroke core region (D–F). eGFP
labels TJs. Biocytin-TMR tracer leakage from
blood vessels into the CNS parenchyma was
visualized 30 min after tail vein injection in (E) and
(F) (red background).
(G–L) Maximum intensity projections of 120-mm-
thick cortical volumes showing TJs in venules and
capillaries of healthy control (G) and diseased
mice 12–14 hr (H), 24–30 hr (I), and 48–58 hr (J–L)
after t-MCAO. Notice the presence of gaps (J and
K; white arrows), protrusions (J and K; arrow-
heads), and aberrant zigzag TJ morphology
(L, yellow arrow) at 48–58 hr. Yellow dots indicate
blood vessel boundaries outlined by the presence
of the tracer (data not shown for simplicity).
(M–O) Bar graphs showing the percent of TJ
strands with gaps (M) and protrusions in venules
(N) and capillaries (O) during stroke progression.
The fraction of TJ strands with gaps or protrusions
in venules, but not capillaries, is significantly
different 48–58 hr after t-MCAO compared to the
control. Data were collected from 2–8 indepen-
dent fields of view (377 mm 3 377 mm) that con-
tained between 61 and 183 TJ strands in either
venules or capillaries from the imaging area (n =
3–5 transgenic animals per time point). Data are
represented as mean ± SEM, *p < 0.05; ***p <
0.001, ****p < 0.0001, mixed effect ANOVA.
See Figure S2 for a quantitative comparison of
biocytin-TMR and IgG leakage during stroke
progression in wild-type versus Tg eGFP-
Claudin5 mice and Movies S1 and S2. Scale bar,
50 mm in (C)–(J) and 25 mm in (K) and (L).
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endothelial TJs accounts for the biphasic opening of the BBB
in stroke (Sandoval and Witt, 2008); however, an in vivo dynamic
analysis of this process is lacking. We subjected 8- to 20-week-
old transgenic male mice to t-MCAO for 45 min (Arac et al.,
2011), then imaged changes in endothelial TJ strands and
leakage of tracers across the damaged barrier in 120- to
240-mm-thick cortical volumes within the stroke core area during
a 6–58 hr time period after t-MCAO (Figures 2A, 2B, and 2D–2F;
Movie S2; data not shown). We quantified the percentage of
eGFP+ TJ strands that contain gaps or protrusions as a measure
of TJ disassembly and remodeling. We found that a significant
fraction (34.3%) of eGFP+ TJ strands had large gaps, ranging
from 0.5 to 4.0 mm, by 48–58 hr after t-MCAO, compared to
7.5% and 9% at 12–14 hr and 24–30 hr after t-MCAO, respec-
tively, or healthy controls (4.5%) (Figures 2G–2J and 2M; p <
0.0001). In addition, many eGFP+ TJs strands in venules606 Neuron 82, 603–617, May 7, 2014 ª2014 Elsevier Inc.(22%), but not capillaries, had multiple protrusions at 48–58 hr
after t-MCAO (Figures 2J, 2K, 2N, and 2O) and an aberrant
zigzag appearance (Figure 2L) reminiscent of ZO-1/2-deficient
epithelial cells (Umeda et al., 2006). These data suggest that
TJs undergo remodeling and structural changes predominantly
between 48–58 hr after t-MCAO.
To examine whether structural abnormalities between endo-
thelial TJs are dynamic in healthy cortex or within the core and
penumbra regions during stroke progression, we subjected
8- to 20-week-old mice to continual two-photon time-lapse
imaging over many days. These mice had a polished, reinforced
thinned-skull window (Drew et al., 2010) andwere imaged before
and at three time points after a 45 min t-MCAO. Each recording
session lasted 2 hr with repeated optical recordings (every 15–
25 min) from distinct cortical volumes (Figure 3A). This allowed
us to follow the same cortical blood vessels in healthy or stroke
animals overmultiple days and to quantify changes in endothelial
Figure 3. Continual Two-Photon Time-Lapse Imaging of Cortical Endothelial TJs in Healthy and Diseased Tg eGFP-Claudin5 Mice Reveals
that Protrusions but Not Gaps Are Highly Dynamic 48–58 hr after t-MCAO
(A) Diagram of the experimental procedure for transcranial two-photon time-lapse imaging of Tg eGFP-Claudin5mice. Four imaging sessions were conducted in
both control and stroke animals. Each session lasted 2 hr and involved repeated optical recordings (every 15–25 min) from distinct cortical volumes. Stroke
animals were imaged once before and three times after t-MCAO (6 hr or 12 hr, then 24 hr and 48 hr). Controls were imaged at corresponding time points.
Imaging began 24 hr after thinned skull preparation (TSP).
(B–E) Sample time-lapse images of eGFP+ TJs in cortical capillaries from control (B and C) or stroke animals (D and E). Images in (B) and (D) are from different
days/imaging sessions; images in (C) and (E) are from a selected day/imaging session (yellow boxed region in B and D). Stroke images (D and E) are from the
stroke core region, verified post hoc 48–60 hr after t-MCAOby tracer leakage into the parenchyma (data not shown). Cortical capillaries show very few protrusions
in both healthy and stroke core tissue. Protrusions are particularly dynamic during the 47–50 hr period after t-MCAO.
(F–I) Time-lapse imaging example of eGFP+ TJs in cortical venules from control (F and G) or stroke animals (H and I; stroke core region). Venule protrusions are
highly dynamic at several time points after t-MCAO and within the highlighted 2 hr time-lapse period. Venules also have more protrusions than capillaries. Static
protrusions present in all images are labeled in yellow; dynamic protrusions are labeled in red.
(J and K) Time-lapse images of a venule before (J) and after (K) stroke illustrating gap formation (green arrows with letter G). See also Movies S3, S4, S5, S6, S7,
and S8 and Figure S3 for time-lapse images from the penumbra region. Scale bars, 10 mm in (B)–(K).
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While the relationship between large and small vessels did not
change in controls, stroke animals showed major vessel rear-
rangements during stroke progression, probably due to tissue
edema (Figures S3B–S3E). Vessel rearrangements included
shifts of the cortical vessels with respect to dura vessels, which
sometimes impaired recordings from previously imaged struc-tures and changes in intracortical vessel orientation that altered
the angle at which these vessels were viewed across imaging
sessions. Such vessels were excluded from our analysis. We
analyzed dynamic changes in protrusions and gaps in endothe-
lial TJs for both capillaries and venules. Consistent with our
cranial window observations, we found fewer TJ protrusions in
capillaries compared to venules in both healthy and strokeNeuron 82, 603–617, May 7, 2014 ª2014 Elsevier Inc. 607
Figure 4. Ultrastructural Changes in Endothelial TJs Appear at Late
but Not Early Time Points after t-MCAO in Tg eGFP-Claudin5 Mice
(A–F) Transmission electron microscopy (TEM) of TJs in ECs from healthy (A),
contralateral (24 hr after t-MCAO; B), and ipsilateral stroke cortex at 6 hr (C),
12–14 hr (D), 24–30 hr (E), and 48–58 hr (F) after t-MCAO. Note structurally
abnormal TJs that contain large gaps (yellow arrows) within normal regions
(red arrows), in particular 24–30 hr and 48–58 hr after t-MCAO.
(G) Bar graph showing the fraction of TJ strands with gaps during stroke
progression after t-MCAO from TEM analysis. The proportion of TJ strands
with gaps is significantly different 48–58 hr after t-MCAO as compared to other
groups. Data were collected from 65–70 independent fields of view (2.6 mm 3
1.7 mm) that contained between 1–3 TJ strands in either venules or capillaries
(n = 2–5 transgenic animals per time point). Data are represented as mean ±
SEM, ****p < 0.0001, one-way ANOVA. Scale bars, 400 nm. See Figure S4 for
analysis of TJ and basement membrane protein expression during stroke in Tg
eGFP-Claudin5 mice.
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majority of protrusions were very stable in healthy capillaries and
venules (the fraction of dynamic protrusion in TJ venules was
5%–13%, n = 4 animals and 3 time-lapse series/animal). How-
ever, these protrusions moved at a longer timescale (Figures
3B, 3C, 3F, and 3G, yellow and red arrows; Movies S3 and608 Neuron 82, 603–617, May 7, 2014 ª2014 Elsevier Inc.S4). In contrast, TJ protrusions in venules from stroke core and
penumbra cortical regions were highly dynamic during both
short and prolonged time periods, in particular at 48–58 hr after
t-MCAO (the fraction of dynamic protrusion in TJ venules within
the stroke core was 50%–100%, n = 5 animals, and 25%–54%
within the penumbra region at both time points, n = 4 animals,
3 time-lapse series/animal; Figures 3D, 3E, 3H, and 3I; Figures
S3F–S3I; Movies S5, S6, S7, and S8). In contrast, gaps appeared
abruptly within endothelial TJ strands at later stages of t-MCAO,
and they were present throughout the duration of individual 2 hr
imaging sessions even at 48–58 hr after t-MCAO (Figures 3J and
3K, green arrows). These findings suggest that protrusions, but
not gaps, are highly dynamic structures that probably reflect
active TJ remodeling processes.
We determined the fractional biocytin-TMR and vascular IgG
leakage area (i.e., stroke-affected area) in sections along the
rostrocaudal axis after t-MCAO and assessed the ratio of the
average biocytin-TMR or IgG pixel intensity for ipsilateral (iCtx)
or contralateral (cCtx) parietal cortex using wild-type and Tg
eGFP-Claudin5 animals, from 6 to 58 hr after t-MCAO. There
was a gradual, significant increase in the biocytin-TMR and IgG
leakage areas from 6 to 58 hr after t-MCAO for all rostrocaudal
regions of the brain (Figures S2A–S2H, S2I, and S2K; p <
0.0001). However, biocytin-TMR and IgG average pixel inten-
sities in the ipsilateral parietal cortex were significantly increased
only 24–30 hr and 48–58 hr after t-MCAO when compared to
healthy mice (Figures 2E and 2F; Figures S2J and S2L; p <
0.0001). The progressive increase in the biocytin-TMR or IgG
leakage areas, as well as their average pixel intensity within the
ipsilateral cortex over time, was comparable between wild-type
andTgeGFP-Claudin5mice from6 to58hr after t-MCAO (Figures
S2I–S2L). Similar resultswereobtainedusingdextran3 kDa-TMR
(data not shown). Therefore, the fusion protein does not modify
the pathological progressive increase in endothelial paracellular
permeability in response to stroke. We next examined eGFP-
Claudin5, Occludin, and ZO-1 expression at several time points
after t-MCAO, in either healthy or ipsilateral cortex. Occludin
and ZO-1 colocalize with eGFP at endothelial TJs up to 24–
30 hr after t-MCAO, similar to the healthy animals (Figures S4A–
S4C00 andS4E–S4G00). However, eGFPhadapredominantly intra-
cellular, rather than junctional, localization in ECs labeled with
BSL-rhodamine by 48–58 hr after stroke, which is consistent
with reduced Occludin and ZO-1 expression in blood vessels
(Figures S4D–S4D00 and S4H–S4H00). In addition, the endothelial
basement membrane proteins Collagen IV, Laminin-a2, and
Nidogen were also reduced at 48 hr after t-MCAO (Figures S4I–
S4L; data not shown). Therefore, the abundant eGFP-positive
TJ strands having structural abnormalities in vivo between 48
and 58 hr after t-MCAO mirror the loss of TJ protein expression
in the ipsilateral cortex, aswell as theabundant tracer andendog-
enous IgG leakage into the parenchyma.
We also examined ultrastructural changes in TJ morphology
by TEM in Tg eGFP-Claudin5 mice during stroke progression.
Some TJs in ipsilateral cortical blood vessels (venules and cap-
illaries) within the stroke core region had an abnormal appear-
ance; TJs exhibited gaps where adjacent EC membranes had
lost contact with each other (Figures 4C–4F). The membrane
around the gaps lacked electron dense material, suggesting
Figure 5. Early Increase in Endothelial Caveolae within the Cortical Stroke Region from Tg eGFP-Claudin5 Mice after t-MCAO
(A–F) TEM of cortical ECs in healthy (A), contralateral (24 hr after t-MCAO; B), and ipsilateral stroke cortex at 6 hr (C), 12–14 hr (D), 24–30 hr (E), and 48–58 hr (F)
after t-MCAO. The vesicle number in ECs (red arrows) is increased as early as 6 hr after t-MCAO and remains above the control baseline up to 58 hr after t-MCAO.
(G–L) Immuno-EM for Caveolin-1 in healthy (G), contralateral (H), and ipsilateral stroke cortex 6 hr (I), 12–14 hr (J), 24–30 hr (K), and 48–58 hr (L) after t-MCAO. The
number of Cav-1+ vesicles (red arrows) is significantly increased in the stroke cortex at all time points.
(M) Bar graph of the number of Cav1+ caveolae per area from immuno-EM images during stroke progression. The number of caveolae in each section is
significantly higher in the ipsilateral (stroke; orange bars) versus contralateral (blue bars) cortex.
(N) Bar graph of the basal distribution of Cav1+ caveolae in endothelial cells within the imaged area during stroke progression. Caveolae are foundmore frequently
at the basal side of the endothelium in the ipsilateral (orange bars) versus contralateral (blue bars) cortex. Data were accumulated from 20–95 independent fields
of view (2.6 mm 3 1.7 mm) that contained between 1–4 ECs from venules or capillaries either within the cortical stroke core or contralateral region (n = 2–5
transgenic animals per time point). Data are represented as mean ± SEM, *p < 0.05, ***p < 0.001, ****p < 0.0001, one-way ANOVA. Scale bars, 400 nm.
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found in healthy or contralateral cortex (Figures 4A and 4B). The
fraction of abnormal TJs with gaps was highly significant only at
48–58 hr after stroke but not earlier (Figure 4G; 46.1%; p <
0.0001). In addition, TJ gaps became progressively larger be-
tween 24 and 58 hr after t-MCAO, ranging in diameter from 0.2
to 1.2 mm (Figures 4E and 4F). Therefore, severe ultrastructural
TJ abnormalities in the late phase (48–58 hr) closely correlate
with the structural defects found by in vivo two-photon imaging.
Endothelial Caveolae Numbers and Transcytosis Rates
Increase at Early Phases of t-MCAO
Because structural abnormalities in endothelial TJs appear at a
delayed phase of BBB impairment (48–58 hr; Figures 2M and
2N) and correlate with a delay in tracer leakage (Figures S2J
and S2L), we examined whether changes in endocytosis and
transcytosis rates might account for the early rise in BBB perme-
ability during reperfusion. Using both TEM and immunoelectron
microscopy (immuno-EM) for Cav1, we determined the number
of caveolae in healthy or diseased ECs at various stages after
t-MCAO. The average number of caveolae in each immuno-EM
imagewas significantly increased in the ipsilateral cortex as earlyas 6 hr after t-MCAO, compared to contralateral stroke cortex
(Figures 5A–5C, 5G–5I, and 5M; p < 0.0001). In addition, the
size of Cav1-positive vesicles was increased up to 200 nm
(from 50 to 70 nm in healthy tissue) as early as 6 hr after
t-MCAO in the ipsilateral cortex. The number and size of caveo-
lae per EC in sections remained significantly higher than controls
at 12–58 hr after stroke (Figures 5D–5F and 5J–5M). Moreover, a
larger fraction of Cav1+ vesicles were found in the basal side of
the endothelial cells in the ipsilateral cortex 6 hr after t-MCAO,
suggesting that trafficking of these vesicles inside the cell had
changed (Figure 5N). Therefore, ECs respond to ischemic insult
by increasing the number of their caveolae as early as 6 hr after
t-MCAO, consistent with previous findings (Cipolla et al., 2004;
Lossinsky and Shivers, 2004).
We next examined whether the increased endothelial caveo-
lae in early phases of reperfusion reflects an increase in the rates
of endocytosis and transcytosis. We analyzed uptake and trans-
port of fluorescently labeled albumin (alb-Alexa 594) across ECs
in either healthy or stroke cortex, since it crosses the BBB by
receptor-mediated transcytosis/endocytosis or fluid phase
absorption (Schubert et al., 2001; Tiruppathi et al., 2004). We in-
jected Tg eGFP-Claudin5 or wild-type mice with 1% alb-AlexaNeuron 82, 603–617, May 7, 2014 ª2014 Elsevier Inc. 609
Figure 6. Increased Endocytosis and Transcytosis Rates in Brain Endothelium Occur as Early as 6 hr after t-MCAO
(A and B) Diagrams of the experimental procedure (A) and labeling of caveolae and other transcytosis vesicles with albumin-Alexa 594 (alb-Alexa 594; B).
(C–N) Uptake of alb-Alexa 594 in liver (C and D), healthy cortex (E and F), and ipsilateral stroke cortex from 6 to 48 hr after t-MCAO (G–N). Note the increase in alb-
Alexa 594 uptake within CNS endothelium labeled with Glut-1 as early as 6 hr after t-MCAO. Liver ECs are marked with BSL (green; D) and brain ECs with Glut-1
(F, H, J, L, and N) in merged panels. Note the increase in alb-Alexa 594 uptake within CNS endothelium as early as 6 hr after t-MCAO.
(legend continued on next page)
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either brain ECs or parenchyma at various time points (Figures
6A and 6B). The fraction of either the Glut1+ or BSL+ EC area
that was filled with tracer-positive vesicles was significantly
higher in ipsilateral stroke cortical vessels as early as 6 hr after
t-MCAO (37.8%) compared to healthy vessels (4.7%) (Figures
6E–6H and 6O; Figures S5A–S5I). The fraction of tracer uptake
in ipsilateral stroke endothelium was reduced to 24% by 12–
30 hr after t-MCAO but returned to 37% by 48–58 hr; this is likely
due to upregulation in endothelial endocytosis in the second
phase of enhancedBBBpermeability (Figures 6I–6O; Figure S5I).
In addition, the number of alb-Alexa 594-positive vesicles within
the brain parenchyma area was significantly higher in ipsilateral
stroke cortical vessels at both 6 hr and 48 hr after t-MCAO,
compared to healthy vessels (Figure 6P; Figure S5J). Taken
together, the increased caveolae numbers and alb-Alexa 594
uptake in cortical endothelium and transport within the brain
parenchyma, as early as 6 hr after t-MCAO, suggest that upregu-
lation of both endothelial endocytosis and transcytosis accounts
for the initial impaired barrier function during reperfusion.
Mice LackingCaveolin1HaveReducedTranscellular but
Not Paracellular Permeability in Cortical Vessels after
t-MCAO
To assess whether disruption of TJ structural integrity and the in-
crease in paracellular permeability at later phases depends on
upregulation of transcytosis at early stages, we analyzed both
endothelial uptake and transport into brain parenchyma of alb-
Alexa 594 6 hr and 27 hr after t-MCAO, as well as diffusion of
biocytin-TMR across cortical blood vessels at 27 hr, in either
wild-type or Cav1-deficient mice that lack EC caveolae (Drab
et al., 2001; Razani et al., 2001). The mean percentage of
Glut1+ or BSL+ blood vessel surface area filled with alb-Alexa
594 and the amount of tracer transported into the brain paren-
chyma was significantly reduced within the ipsilateral cortex of
Cav1/ mice compared to wild-type controls at both 6 hr and
27 hr after t-MCAO (Figures 7A–7H; Figures S6A and S6B;
data not shown). Some (22%–25%) alb-Alexa 594 was endocy-
tosed in liver or stroke ECs in Cav1-deficient mice; these data
conflict with previous studies suggesting that Cav1 is required
for albumin transport across lung ECs (Schubert et al., 2001)
but may be explained by Cav1-independent endocytosis. We
find that a large fraction of alb-Alexa 594 vesicles colocalize
with EEA-1+ early endosomes but not LAMP1+ lysosomes or
Rab7+ late endosome markers in primary brain ECs (Figures
S6C–S6G). Furthermore, more tracer-positive vesicles are pre-
sent in the early endosome when primary brain ECs are cultured
for 3 days under hypoxic conditions (Figures S6C0–S6G0), sug-
gesting that alb-Alexa 594-positive vesicles are routed toward
the endosome during hypoxic stroke.
We then quantified the biocytin-TMR or IgG leakage area in
tissue sections from wild-type and Cav1-deficient mice 27 hr(O and P) Bar graphs showing the percentage of Glut-1+ endothelial (O) or br
contralateral (blue) cortex. The fraction of endothelial- and parenchyma-filled a
compared to healthy cortex. Data were collected from 4 to 9 independent fields
point). Data are represented as mean ± SEM, *p < 0.05; ****p < 0.0001, mixed ef
endothelial or parenchyma area filled with alb-Alexa 594 in ipsilateral and contraafter t-MCAO. We found that the percentage of the tracer
leakage area was significantly increased in Cav-1/ (45.8%)
compared to wild-type (37%) mice (Figures 8A–8C; Figures
S7A–S7C; p < 0.0001; standard t test), as previously reported
(Jasmin et al., 2007). This difference was largely due to selective
biocytin-TMR or IgG extravasation within the ipsilateral thal-
amus (data not shown). Although the stroke area was increased
in Cav1/ compared to wild-type mice, the ratio of average
biocytin-TMR or IgG pixel intensity between the ipsilateral and
contralateral area was unchanged within anatomically matched
CNS regions between the two strains (Figure 8D; Figure S7D).
Moreover, expression levels, subcellular localization of several
TJ proteins (Claudin5, Occludin, and ZO-1), and TJ ultra-
structural morphology by TEM in healthy brain ECs are undistin-
guishable between Tg eGFP-Claudin5 Cav-1/ mice and Tg
eGFP-Claudin5 littermates (Figures 8E–8H; Figures S7E–S7J),
suggesting that Cav1 is not required for proper formation of
CNS endothelial TJs as had been suggested (Schubert et al.,
2002). Therefore, the increase in paracellular permeability ob-
served in Cav1/ CNS endothelium in stroke is not due to
aberrant formation of TJs in the healthy brain but is rather a
normal physiological response of mutant endothelial cells to
pathological stimuli. These findings suggest that Cav1 controls
the transcellular but not paracellular mechanisms responsible
for increased cortical blood vessel permeability in response to
ischemic stroke.
DISCUSSION
Multiple components of the NVU respond rapidly and simulta-
neously to ischemic injury in a coordinated manner (del Zoppo,
2010). The sequence of endothelial cell biological mechanisms
that impair BBB function during stroke in vivo, however, remains
controversial (Lossinsky and Shivers, 2004; Sandoval and Witt,
2008). We have addressed this controversy with the genera-
tion of Tg eGFP-Claudin5 transgenic mice and two-photon
imaging in live animals to examine structural changes in CNS
endothelial TJs within the cortical core and peri-infarct areas
in the t-MCAO model for stroke. We find that major TJ structural
abnormalities occur at 48–58 hr after t-MCAO, a late phase of
stroke progression. In addition, our study reveals that BBB
disruption in response to ischemia involves sequential activa-
tion of two distinct mechanisms, beginning with upregulation
of endothelial transcytosis in the early phase of reperfusion
(6 hr) followed by major remodeling of TJ complexes in the
late phase (24–48 hr). The timescale for increased BBB perme-
ability to tracers that primarily cross the barrier via transcellular
rather than paracellular pathways matches the sequence of
structural changes in ECs during reperfusion, suggesting that
current models of how BBB disruption occurs in stroke must
be reconsidered (Sandoval and Witt, 2008). Disruption of
the paracellular barrier in gut epithelial cells in response toain parenchyma (P) area filled with alb-Alexa 594 in ipsilateral (orange) and
rea with alb-Alexa 594 is significantly higher at 6 hr and 48 hr after t-MCAO
of view that contained cortical venules or capillaries (n = 3–5 animals per time
fect ANOVA. Scale bars, 50 mm. See Figure S5 for analysis of percent of BSL+
lateral cortex.
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Figure 7. Reduced Endothelial Endocytosis and Transcytosis in Caveolin1-Deficient Mice in Response to Stroke
(A–F0) Uptake of alb-Alexa 594 in liver (A–B0) and ipsilateral stroke cortex (C–F0) 6 hr and 27 hr after t-MCAO inwild-type orCav1/mice. Note the decrease in alb-
Alexa 594 uptake by ECs in liver or ipsilateral cortex for mutant versus wild-typemice. Liver ECs are labeled with BSL-FITC (green; A–B0) and brain ECs with Glut1
(green; C–F0 ) in merged panels.
(G andH) Bar graphs showing the fraction of Glut1+ endothelial (G) or parenchymal (H) area filled with alb-Alexa 594 in the ipsilateral cortex of wild-type (orange) or
Cav1/ (blue) mice, 6 hr and 27 hr after t-MCAO. The percentage of endothelial and parenchymal area filled with alb-Alexa 594 is significantly reduced 6 hr and
27 hr after t-MCAO in Cav-1/mice compared to controls. Data were collected from 4 to 9 independent fields of view that contain cortical venules or capillaries
from wild-type (n = 3) or Cav1/ (n = 3) mice per time point. Data are represented as mean ± SEM, *p < 0.05; ****p < 0.0001, paired t test. Scale bars, 50 mm in
(A)–(F0 ). See Figure S6 for quantitative analysis of the fraction of BSL+ endothelial or parenchymal area filled with alb-Alexa 594 in the ipsilateral cortex from wild-
type or Cav1/ mice, 6 hr and 27 hr after t-MCAO, and characterization of Alb+ Cav1 vesicles in primary brain endothelial cells.
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mediated endocytosis followed by TJ remodeling (Marchiando
et al., 2010). These cellular events may therefore represent a
general principle for how tissues possessing barrier properties
respond to injury.612 Neuron 82, 603–617, May 7, 2014 ª2014 Elsevier Inc.Tg eGFP-Claudin5 Transgenic Mice as a Genetic Tool to
Study Endothelial TJ Dynamics and Immune Cell
Interactions in CNS Disease
TJs have traditionally been viewed as stable structures (Bright-
man and Reese, 1969). However, imaging of eGFP-tagged TJ
Figure 8. Cav1-Deficient Mice Exhibit an
Increase in Paracellular Endothelial Perme-
ability Similar to Wild-Type Mice after
t-MCAO
(A and B) Brain sections from wild-type (A) or
Cav1/ (B) mice showing Biocytin-TMR leakage
27 hr after t-MCAO. The area of biocytin-TMR
leakage and the outline of the brain section are
marked with dashed white lines. Note the exten-
sive leakage of tracer into the cortex and putamen.
The choroid plexus (A and B; arrows) is intensely
labeled due to lack of the barrier. (A0 and B0)
Higher-magnification images for the yellow
squares shown in (A and B).
(C) Bar graph showing the fraction of biocytin-
TMR leakage area in wild-type or Cav1/ mice.
The increased fraction of biocytin-TMR areas in
mutant mice is due to tracer in the thalamus.
(D) Bar graph of the biocytin-TMR average pixel
intensity ratio between ipsilateral and contralateral
areas for cortex, putamen, and hippocampus in
wild-type (orange bars) or Cav1/ (blue bars)
mice. There is no significant difference in biocytin-
TMR leakage intensity for matched anatomical
regions. Data are represented as mean ± SEM,
****p < 0.0001, paired t test.
(E–H) Expression of eGFP-Claudin5, Claudin5,
Occludin, and ZO-1 in Tg eGFP-Claudin5 (E and F)
and Tg eGFP-Claudin5 Cav1/ (G andH)mice. TJ
proteins are correctly localized in CNS ECs of both
strains.
(I) Schematic representation of increases in
biocytin-TMR (blue), IgG (green), and alb-Alexa
594 (red) over time after t-MCAO. There is a
nonlinear, gradual increase in biocytin-TMR and
IgG permeability during stroke progression that
becomes significant 24–48 hr after t-MCAO and
correlates with the abundance of structural de-
fects in TJs (i.e., junction remodeling). In contrast,
alb-Alexa 594 uptake increases as early as 6 hr
after t-MCAO, suggesting that endocytosis and
transcytosis are increased in early phases of
ischemic stroke. Upregulation of both Cav1-
dependent and -independent endothelial trans-
cytosis, followed by TJ disassembly, contribute to
enhanced BBB permeability after t-MCAO. Scale
bars, 400 mm in (A) and (B) and 50 mm in (E)–(H).
See Figure S7 for analysis of IgG leakage after
stroke, the morphology of TJs with TEM and TJ
protein levels in wild-type versus Cav1/ brains.
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dynamic remodeling in both healthy and disease states (Shen
et al., 2008; Marchiando et al., 2010). The BBB undergoes rapid
changes in permeability in response to CNS insults, yet tradi-
tional approaches for studying barrier permeability do not
provide either dynamic measurement of BBB breakdown during
disease or correlation with structural endothelial abnormalities.
To overcome this obstacle, we developed a transgenic mouse
strain that expresses eGFP fused to the N terminus of Claudin5
in ECs to maintain its interactions with ZO-1 (Piontek et al., 2008)
and two-photon imaging assays for combined measurement of
TJ dynamics and tracer leakage in cortical vessels in vivo. These
Tg eGFP-Claudin5 mice are a genetic tool to enable dynamicanalysis of TJ formation in blood vessels during development,
TJ breakdown associated with increased vascular permeability,
aswell as dynamic interactions of the endotheliumwith either im-
mune cells or parasites during CNS diseases (Zlokovic, 2008).
Overexpressing eGFP-Claudin5 has the potential to affect
endothelial barrier function, since Claudin5 levels are essential
for size selectivity of the paracellular barrier (Nitta et al., 2003).
However, we find no evidence for reduced permeability of non-
CNS endothelium in healthy Tg eGFP-Claudin5 compared to
wild-type mice (Figure S1). Moreover, the gradual increase
in endothelial paracellular permeability to small tracers (e.g.,
biocytin-TMR) or IgG after ischemic stroke is identical between
transgenic and wild-type littermates. Finally, our analysis ofNeuron 82, 603–617, May 7, 2014 ª2014 Elsevier Inc. 613
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two-photon microscopy correlates well with TJ structural aber-
rations identified by TEM and immunofluorescence. Therefore,
Tg eGFP-Claudin5 transgenic mice can be used to detect dy-
namic changes in endothelial TJs during disease.
Stepwise Recruitment of Transcellular and Paracellular
Pathways Accounts for Changes in Endothelial Barrier
Properties during Stroke Progression
Despite the obvious clinical and therapeutic relevance, satisfac-
tory mechanisms for how the NVU in toto responds to stroke,
and how BBB integrity is impaired at the cell biological level,
are lacking. Active disassembly and reassembly of TJ protein
complexes has been considered to play a major role in the
biphasic opening of the BBB during reperfusion (Sandoval and
Witt, 2008); however, our data do not support this model. We
find that major abnormalities within TJ strands (e.g., gaps or pro-
trusions) aremostly present 48–58 hr after t-MCAO, correspond-
ing to the second peak of biphasic increase in BBB permeability,
while during the early phase of enhanced permeability, TJ
strands are relatively normal in the ipsilateral stroke cortex. Our
repeated time-lapse recordings within the same vessels before
and after t-MCAO demonstrate that protrusions are particularly
dynamic 48 hr after t-MCAO. Therefore, active remodeling of
TJ proteins appears not to play an important role in increased
BBB permeability during the early phase of reperfusion. Several
additional lines of evidence support our conclusion. First, TEM
and immunofluorescence assays for TJ morphology changes
agree with our two-photon imaging data, arguing against a
limitation in detecting early TJ defects by two-photon imaging.
Second, while t-MCAO typically results in infarction of the basal
ganglia with less severe deficits in the cerebral cortex, due to a
compensatory circulatory system from surface-communicating
arterioles (Schaffer et al., 2006), the parietal cortex area imaged
was located within the stroke or penumbra region based on three
criteria: (1) early changes in endothelial caveolae and the rates of
transcytosis visualized by TEM and tracer uptake, respectively;
(2) motor deficits in animals after recovery from t-MCAO (data
not shown); and (3) anatomical distribution of biocytin-TMR
6–58 hr after t-MCAO after dynamic imaging. Finally, the kinetics
of biocytin-TMR or IgG extravasation during stroke do not mimic
the well-characterized biphasic increase in BBB permeability
measured with Evans blue in various animal models (Sandoval
and Witt, 2008) since their endothelial permeability increases
gradually between 20 and 58 hr after t-MCAO (Figure 8I, blue
and green lines), consistent with the appearance of TJ structural
abnormalities. Normal TJs have also been found 25 hr after
ischemia in an embolic MCAO rat model (Krueger et al., 2013),
suggesting that delayed TJ remodeling is a common feature of
the CNS endothelial response to various forms of stroke.
What accounts for early changes in BBB permeability after
ischemic stroke? Our structural analysis clearly demonstrates
that the number of endothelial caveolae is increased as early
as 6 hr after t-MCAO in the parietal cortex. These findings are
consistent with reports that CNS ECs upregulate transcellular
vesicular transport in response to hypertension and cerebral
ischemia/stroke (Ito et al., 1980; Dietrich et al., 1987; Cipolla
et al., 2004; Lossinsky and Shivers, 2004). Consistent with614 Neuron 82, 603–617, May 7, 2014 ª2014 Elsevier Inc.increased caveolae numbers, endothelial uptake and transport
of alb-Alexa 594 into the brain parenchyma is enhanced as early
as 6 hr after t-MCAO. The kinetics of alb-Alexa 594 uptake during
reperfusion follows the canonical biphasic increase in BBB
permeability, with higher rates at 6 and 48–58 hr and lower rates
12–30 hr after stroke (Figure 8I). Although Cav1 levels increase
within the stroke core region after t-MCAO (Jasmin et al.,
2007), endothelial uptake of alb-Alexa 594 after ischemia seems
to be mediated by both Cav1-dependent and -independent
endocytosis, since uptake is reduced but not completely abol-
ished in Cav1/ mice (Figure 7; Figure S6). We propose that
barrier permeability during reperfusion has two steps: (1) initial
upregulation of endothelial transcytosis that accounts for the
early peak in enhanced BBB permeability and (2) delayed re-
modeling and disassembly of TJ protein complexes in the
second phase that exacerbates barrier dysfunction, leading to
progressive demise of the perinfarct area (Figure 8I). The selec-
tive reduction in transcellular but not paracellular permeability in
cortical blood vessels of Cav-1-deficient mice after stroke sug-
gests that these two processes are regulated independently.
Since both expression and localization of several BBB TJ pro-
teins are normal in healthy Cav1/ CNS ECs, their increase in
paracellular permeability during t-MCAO is not due to inherently
defective TJs inCav1/ endothelial cells but rather is a standard
physiological response of the mutant endothelium to ischemia. It
is possible that dynamic properties of endothelial TJs may be
different between wild-type and Cav1/ mice; however, dy-
namic imaging of TJs with pharmacological inhibition of transcy-
tosis in vivo would not allow us to parse out its role in endothelial
cells versus other components of the NVU.
Disruption of the paracellular barrier in gut epithelial cells in
response to TNFa-induced inflammation is also mediated
by an increase in Cav1-dependent endocytosis, followed by
Occludin internalization and disruption of TJ strands (March-
iando et al., 2010). Pharmacological or genetic inactivation of
Cav1 prevents TNFa-induced enhancement in paracellular
permeability and TJ remodeling in gut epithelial cells, suggesting
that these two processes are tightly linked (Marchiando et al.,
2010). These findings contrast with our observations that endo-
thelial paracellular permeability does not depend on Cav1 func-
tion in ischemic stroke. Such differences between endothelial
and epithelial responses may be due to the inherent dissimilarity
between these barriers or may reflect distinct types of patholog-
ical insult (inflammation versus hypoxia).
Why do ECs respond initially during ischemic stroke by chang-
ing their rate of transcytosis? One potential explanation relies on
the early separation and migration of pericytes away from brain
microvessels within 2 hr after focal cerebral ischemia, due to
dissolution of the basement membrane (Dore-Duffy et al.,
2000; Liu et al., 2012b). Pericytes regulate BBB formation and
maintenance by secreting inhibitory signals that reduce the num-
ber of caveolae and rate of endothelial transcytosis (Armulik
et al., 2010; Daneman et al., 2010b). Pericyte detachment may
relieve an important inhibitory mechanism that is required to
maintain low transcytosis in CNS blood vessels. However, it
is unclear if increased endothelial transcytosis provides a
beneficial signal to the NVU during the initial phase of stroke pro-
gression. Later, disruption of basement membranes by
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cytokines in the stroke region, upregulation of endothelial
eNOS signaling, and production of angiogenic growth factors
such as VEGF and angiopoietins can all lead to secondary disso-
lution of TJ structure and function and enhanced TJ remodeling
(Arai et al., 2011). This process may function in parallel with
upregulation of endothelial transcytosis to impair BBB function
in ischemic stroke.
EXPERIMENTAL PROCEDURES
Generation of Tg eGFP-Claudin5 Transgenic Mice
An N-terminal fusion of eGFP with mouse Claudin5 was inserted downstream
of the 2.5 kb murine Tie2/Tek1 promoter and upstream of a 10 kb enhancer
that includes exon 1 (Evans et al., 2000). We obtained 8 founder lines, of which
2 (lines 4 and 15) showed strong expression throughout the vasculature. Line
15 was used for most experiments described in this study.
Mouse Ischemic Stroke Model and Two-Photon In Vivo Imaging
All experimental procedures were approved by the IACUC committees at the
University of California at Irvine, Stanford University, and the Salk Institute for
Biological Studies. We subjected 8- to 20-week-old male mice weighing 25–
30 g to t-MCAO as described in Arac et al. (2011). Head plate implantation
surgery was performed as described in Nimmerjahn (2012b). For one-time
imaging, a craniotomy was performed (typically 1.3–2.0 mm in diameter at
around1.0mmpostbregma and 3.5mm lateral), leaving the duramater intact
(Nimmerjahn, 2012a). For repeated imaging, a thinned skull window was pre-
pared 24 hr prior to imaging (typically 1.0–1.5 mm in diameter at around
1.0 mm post bregma and 3.5 mm lateral, reinforced with a #0 coverslip
[Thomas Scientific]) (Drew et al., 2010). Blood plasma was labeled by tail vein
injection of biocytin-TMR or 3,000 MW Dextran-TMR (1% in PBS). Imaging
was performed on an upright two-photon microscope equipped with a pulsed
femtosecond Ti:Sapphire laser (Chameleon Ultra II, Coherent or Tsunami,
Spectra-Physics), two fluorescence detection channels, and water-immersion
objectives. Further details are provided in the Supplemental Experimental
Procedures.
Immunofluorescence and Tracer Leakage Quantitation
Brain, muscle, liver, and kidney from C57BL6/J, Tg eGFP-Claudin5, Cav1/,
or Tg eGFP-Claudin5 Cav1/ mice were harvested 30–45 min after tail vein
injection with 1% biocytin-TMR or alb-Alexa 594 solution (Life Technologies).
Brain or liver blood vessels were labeled by immunofluorescence with anti-
bodies for Glut-1, BSL-FITC, or BSL-Rhodamine. Streptavidin-Alexa 594
(Life Technologies) was used to visualize biocytin-TMR distribution in tissues.
Sections were imaged with an upright Zeiss Axioimager and biocytin-TMR or
IgG leakage was quantified with Fiji software. See the Supplemental Experi-
mental Procedures for more details.
Transmission Electron Microscopy and Immunoelectron
Microscopy
TEM samples from healthy, ipsilateral, or contralateral stroke cortex were fixed
in Karnovsky’s fixative for 1 hr at room temperature followed by overnight fix-
ation at 4C. For immuno-EM, brains were fixed in 4% warm PFA for 6 hr,
sectioned, and stained for Cav1 (1:1,000) followed by incubation with Nano-
gold anti-rabbit IgG (1:50; Nanoprobes). Gold particles were enhanced with
the HQ Silver Enhancement Kit (Nanoprobes). Stained sections were pro-
cessed for TEM and imaged with a JEOL 1230 TEM at 80 kV. Photos were
taken with a Gatan Orius digital camera. We obtained approximately 70
images of caveolae per sample. The numbers of Cav1+ vesicles visualized
by immuno-EMwere counted from each image and averaged for each sample.
TJ Quantitation
Maximum intensity projections were created for each image stack/3D
recording volume in order to quantify TJ abnormalities in two-photon time-
lapse data for each time point. We then determined the number and percent-age of TJ strands with protrusions or gaps and the fraction of dynamic
protrusions and gaps. Blood vessel borders were defined by the presence
of tracers. To quantify TJ strands with abnormal morphology in EM data, we
obtained approximately 70 images of TJs for each EM sample, counted the
number of TJ strands with abnormalities (gaps) per image, and calculated
the percent of abnormal versus total TJs (further details are found in the Sup-
plemental Experimental Procedures).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, one table, and eight movies and can be found with this article
online at http://dx.doi.org/10.1016/j.neuron.2014.03.003.
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